In a filing, Nurix Therapeutics Inc revealed its Chief Financial Officer van Houte Hans unloaded Company’s shares for reported $44878.0 on May 02 ’24. In the deal valued at $12.83 per share,3,499 shares were sold. As a result of this transaction, van Houte Hans now holds 68,333 shares worth roughly $0.9 million.
Then, Hansen Gwenn sold 2,007 shares, generating $24,169 in total proceeds. Upon selling the shares at $12.04, the Chief Scientific Officer now owns 39,601 shares.
Before that, Ring Christine sold 1,513 shares. Nurix Therapeutics Inc shares valued at $18,220 were divested by the Chief Legal Officer at a price of $12.04 per share. As a result of the transaction, Ring Christine now holds 19,838 shares, worth roughly $0.26 million.
A number of analysts have revised their coverage, including Barclays’s analysts, who began to cover the stock in early March with a ‘”an Overweight”‘ rating. Oppenheimer began covering NRIX with “an Outperform” recommendation on February 28, 2023. Morgan Stanley started covering the stock on October 11, 2022. It rated NRIX as “an Equal-weight”.
Price Performance Review of NRIX
On Monday, Nurix Therapeutics Inc [NASDAQ:NRIX] saw its stock jump 3.44% to $13.22. Over the last five days, the stock has gained 6.01%. Nurix Therapeutics Inc shares have risen nearly 28.10% since the year began. Nevertheless, the stocks have risen 40.04% over the past one year. While a 52-week high of $18.12 was reached on 04/11/24, a 52-week low of $4.22 was recorded on 01/29/24. SMA at 50 days reached $13.83, while 200 days put it at $9.51. A total of 0.44 million shares were traded, compared to the trading of 1.2 million shares in the previous session.
Levels Of Support And Resistance For NRIX Stock
The 24-hour chart illustrates a support level at 12.82, which if violated will result in even more drops to 12.43. On the upside, there is a resistance level at 13.56. A further resistance level may holdings at 13.91. The Relative Strength Index (RSI) on the 14-day chart is 48.04, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.27, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 60.24%. Stochastics %K at 27.39% indicates the stock is a holding.
